제품문의

레타트루타이드 5mg/10mg은 GLP-1을 나타냅니다.

생산물 기술: 레타트루타이드, as described in the information provided, is a novel peptide that acts as a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1 (영문)), and glucagon receptors. It has shown promising results in treating metabolic dysfunction-associated steatotic liver disease (MDASLD) and obesity-related conditions. Here are the key findings from the study: Study Details and Results…